ABE-Mediated Cardiac Gene Silencing via Single AAVs Requires DNA Accessibility

share:

Brief intro:

  • Author: Zhanzhao Liu, Luzi Yang, Yuhan Yang, Jiting Li, Congting Guo, Qianhao Guo, Dongyu Zhao, Fei Gao, and Yuxuan Guo
  • Journal: Circulation Research
  • Publication Date: 2025 Jan 16

Products/Services used in the paper

Request Quote

About PackGene

PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions. Leveraging our groundbreaking π-alpha 293 AAV high-yield platform, we amplify AAV production by up to 10-fold, yielding up to 1e+17vg per batch to meet diverse commercial and clinical project needs. Moreover, our tailored mRNA and LNP products and services cater to every stage of drug and vaccine development, from research to GMP production, providing a seamless, end-to-end solution.

Download